• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解 Fc 功能,有助于针对病原体进行合理的疫苗设计。

Understanding Fc function for rational vaccine design against pathogens.

机构信息

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

mBio. 2024 Jan 16;15(1):e0303623. doi: 10.1128/mbio.03036-23. Epub 2023 Dec 19.

DOI:10.1128/mbio.03036-23
PMID:38112418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10790774/
Abstract

Antibodies represent the primary correlate of immunity following most clinically approved vaccines. However, their mechanisms of action vary from pathogen to pathogen, ranging from neutralization, to opsonophagocytosis, to cytotoxicity. Antibody functions are regulated both by antigen specificity (Fab domain) and by the interaction of their Fc domain with distinct types of Fc receptors (FcRs) present in immune cells. Increasing evidence highlights the critical nature of Fc:FcR interactions in controlling pathogen spread and limiting the disease state. Moreover, variation in Fc-receptor engagement during the course of infection has been demonstrated across a range of pathogens, and this can be further influenced by prior exposure(s)/immunizations, age, pregnancy, and underlying health conditions. Fc:FcR functional variation occurs at the level of antibody isotype and subclass selection as well as post-translational modification of antibodies that shape Fc:FcR-interactions. These factors collectively support a model whereby the immune system actively harnesses and directs Fc:FcR interactions to fight disease. By defining the precise humoral mechanisms that control infections, as well as understanding how these functions can be actively tuned, it may be possible to open new paths for improving existing or novel vaccines.

摘要

抗体是大多数经临床批准的疫苗接种后产生免疫的主要相关物。然而,它们的作用机制因病原体而异,包括中和、调理吞噬作用和细胞毒性。抗体的功能既受抗原特异性(Fab 结构域)的调节,也受其 Fc 结构域与免疫细胞中存在的不同类型 Fc 受体(FcR)相互作用的调节。越来越多的证据强调了 Fc: FcR 相互作用在控制病原体传播和限制疾病状态方面的关键性质。此外,在感染过程中 FcR 结合的变化已在一系列病原体中得到证实,并且这可以进一步受到先前暴露/免疫接种、年龄、妊娠和潜在健康状况的影响。Fc: FcR 功能的变化发生在抗体同种型和亚类选择以及抗体的翻译后修饰水平,这些修饰会影响 Fc: FcR 相互作用。这些因素共同支持了一种模型,即免疫系统积极利用和指导 Fc: FcR 相互作用来对抗疾病。通过确定控制感染的确切体液机制,以及了解如何主动调整这些功能,也许可以为改进现有或新型疫苗开辟新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a2/10790774/1aa6abe00d80/mbio.03036-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a2/10790774/ee5dbd1d4eb9/mbio.03036-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a2/10790774/1aa6abe00d80/mbio.03036-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a2/10790774/ee5dbd1d4eb9/mbio.03036-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a2/10790774/1aa6abe00d80/mbio.03036-23.f002.jpg

相似文献

1
Understanding Fc function for rational vaccine design against pathogens.理解 Fc 功能,有助于针对病原体进行合理的疫苗设计。
mBio. 2024 Jan 16;15(1):e0303623. doi: 10.1128/mbio.03036-23. Epub 2023 Dec 19.
2
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.额外的中和 FcR 介导的抗体功能用于通用流感疫苗。
Front Immunol. 2019 Mar 18;10:440. doi: 10.3389/fimmu.2019.00440. eCollection 2019.
3
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Fc 介导的呼吸道合胞病毒感染和疾病中的抗体效应功能。
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
4
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.广泛中和的血凝素茎特异性抗体以Fc依赖的方式诱导中性粒细胞对免疫复合物进行有效的吞噬作用。
mBio. 2016 Oct 4;7(5):e01624-16. doi: 10.1128/mBio.01624-16.
5
The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity.宿主和病毒抗体 Fc 受体在单纯疱疹病毒 (HSV) 和人类巨细胞病毒 (HCMV) 感染和免疫中的作用。
Front Immunol. 2019 Sep 6;10:2110. doi: 10.3389/fimmu.2019.02110. eCollection 2019.
6
Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.病原体识别 Toll 样受体与免疫球蛋白 Fc 受体间的串扰在免疫中的作用。
Immunol Rev. 2015 Nov;268(1):311-27. doi: 10.1111/imr.12333.
7
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations.通过操纵 Fc 结构域改善抗体治疗:免疫和结构方面的考虑。
Annu Rev Biomed Eng. 2022 Jun 6;24:249-274. doi: 10.1146/annurev-bioeng-082721-024500. Epub 2022 Apr 1.
8
Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.抗体功能测定作为Fc受体介导的HIV免疫的衡量指标——新技术及其对HIV疫苗领域的影响
Curr HIV Res. 2017;15(3):202-215. doi: 10.2174/1570162X15666170320112247.
9
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
10
Signaling by Antibodies: Recent Progress.抗体信号传导:最新进展
Annu Rev Immunol. 2017 Apr 26;35:285-311. doi: 10.1146/annurev-immunol-051116-052433.

引用本文的文献

1
Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus.针对猪流行性腹泻病毒和传染性胃肠炎病毒的二价环状RNA疫苗。
Front Immunol. 2025 Mar 31;16:1562865. doi: 10.3389/fimmu.2025.1562865. eCollection 2025.
2
Antibodies as key mediators of protection against .抗体作为预防 …… 的关键介质。
Front Immunol. 2024 Sep 2;15:1430955. doi: 10.3389/fimmu.2024.1430955. eCollection 2024.
3
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques.

本文引用的文献

1
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.一种采用AS03佐剂的变异适应型SARS-CoV-2重组蛋白疫苗作为加强针在已接种授权疫苗的成年人中的安全性和免疫原性:一项3期平行组研究。
EClinicalMedicine. 2023 Jul 22;62:102109. doi: 10.1016/j.eclinm.2023.102109. eCollection 2023 Aug.
2
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.针对埃博拉病毒可溶性糖蛋白的抗体与非人类灵长类动物的长期疫苗介导保护有关。
Cell Rep. 2023 Apr 25;42(4):112402. doi: 10.1016/j.celrep.2023.112402. Epub 2023 Apr 15.
3
猕猴中针对新冠病毒奥密克戎毒株的组织特异性抗体保护相关性
iScience. 2024 Jun 4;27(9):110174. doi: 10.1016/j.isci.2024.110174. eCollection 2024 Sep 20.
4
Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model.疫苗平台比较:在仓鼠模型中对致命马尔堡病毒挑战的保护效力。
Int J Mol Sci. 2024 Aug 5;25(15):8516. doi: 10.3390/ijms25158516.
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2.
Fc-γR 依赖性抗体效应功能是疫苗介导预防 SARS-CoV-2 抗原漂移变体所必需的。
Nat Microbiol. 2023 Apr;8(4):569-580. doi: 10.1038/s41564-023-01359-1. Epub 2023 Apr 3.
4
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.Fc 介导的泛沙贝病毒保护作用:在黄病毒载体疫苗接种后。
Cell Rep. 2023 Apr 25;42(4):112326. doi: 10.1016/j.celrep.2023.112326. Epub 2023 Mar 30.
5
Mechanism of activation and biased signaling in complement receptor C5aR1.补体受体 C5aR1 的激活和偏倚信号转导机制。
Cell Res. 2023 Apr;33(4):312-324. doi: 10.1038/s41422-023-00779-2. Epub 2023 Feb 17.
6
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.奥密克戎亚变种 BA.2.75.2、BA.4.6 和 BQ.1.1 对中和抗体的耐药性。
Nat Commun. 2023 Feb 14;14(1):824. doi: 10.1038/s41467-023-36561-6.
7
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种BQ.1.1和XBB.1的显著中和逃逸
N Engl J Med. 2023 Feb 16;388(7):662-664. doi: 10.1056/NEJMc2214314. Epub 2023 Jan 18.
8
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.令人担忧的 SARS-CoV-2 BQ 和 XBB 亚型不断出现的抗体逃逸特性。
Cell. 2023 Jan 19;186(2):279-286.e8. doi: 10.1016/j.cell.2022.12.018. Epub 2022 Dec 14.
9
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
10
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children.SARS-CoV-2 mRNA 疫苗可在儿童中引发强烈的抗体反应。
Sci Transl Med. 2022 Nov 23;14(672):eabn9237. doi: 10.1126/scitranslmed.abn9237.